Risk Minimisation Evaluation with Process Indicators and Behavioural or Health Outcomes in Europe: Systematic Review.
Esther ArtimeNawab QizilbashRafael HerruzoMacarena Garrido-EstepaPublished in: Pharmaceutical medicine (2020)
A minority of RMEv assessed both process indicators and outcomes. More RMEv require approaches that correlate process indicators and outcomes at the patient level to evaluate more comprehensively the implementation of aRMMs.